Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Industry/Academia Advocacy Group Presses For Stable NIH Funding

This article was originally published in The Gray Sheet

Executive Summary

United for Medical Research, a year-old advocacy organization that boasts BIO as a founding member, is bringing academic and industry groups together in a long-range effort to end the boom-or-bust funding cycles experienced by the National Institutes of Health

You may also be interested in...



Senate Subcommittee Explores Innovation Strategy, With Device Emphasis

Device, investor and technology leaders told a U.S. Senate subcommittee on June 22 that they want a more thoughtful national strategy on innovation competitiveness - one that increases collaboration between industry and university researchers and reforms often confusing regulatory roadblocks

Senate Subcommittee Explores Innovation Strategy, With Device Emphasis

Device, investor and technology leaders told a U.S. Senate subcommittee on June 22 that they want a more thoughtful national strategy on innovation competitiveness - one that increases collaboration between industry and university researchers and reforms often confusing regulatory roadblocks

People In Brief

Terumo Heart: Ann Arbor, Mich., subsidiary of the Japanese conglomerate names Thomas Gould as VP-clinical affairs and Mark Bullivant as director for international sales on Aug. 5, adding to the firms burgeoning left ventricular assist device unit. Gould comes from a VP of sales and marketing post at VentraAssist VAD developer Ventricor, which announced in March that it has run out of money. He will oversee Terumo's 140-patient U.S. pivotal trial for the DuraHeart ventricular assist device as a bridge-to-transplant (1"The Gray Sheet" April 13, 2009). Bullivant joins Terumo from St. Jude Medical's international cardiac surgery business and will focus on developing Terumo's international DuraHeart business, the company says

Related Content

Topics

UsernamePublicRestriction

Register

MT028529

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel